Advokatfirman Lindahl advises Stille on a directed share issue of SEK 425 million in conjunction with Stille’s acquisition of Fehling

Lindahl has acted as advisor in connection with Stille AB (publ)'s directed share issue of approximately SEK 425 million. The proceeds are intended to be used to finance the acquisition of Fehling.

Fehling is a family-owned German company that develops and sells high-quality medical instruments. Fehling has a strong market position with direct operations in Germany, Switzerland, the US, Singapore, the United Arab Emirates and Malaysia.

Stille develops, manufactures and markets medical devices for specialist surgeons worldwide. Stille is one of the world's oldest medical technology companies, with a focus on surgical instruments and operating tables. The company has a stable base with a strong brand and well-known products of recognized high quality.

Pareto Securities AB has acted as Sole Manager and Bookrunner.

Lindahl's team mainly consisted of Ola Svanberg, Victoria Skoglund, Gustav Ahlgren, Jakob Josefsson and Ebba Meyer-Lie.

Capital Markets | Public M&A

Lindahl assists companies with stock market listings, issuances, and regulations within the securities market.

Related cases & articles